182 related articles for article (PubMed ID: 36722197)
1. Host factors predisposing to kidney disease in people with HIV.
Hung RKY; Winkler CA; Post FA
Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
[TBL] [Abstract][Full Text] [Related]
2. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
[TBL] [Abstract][Full Text] [Related]
3. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.
Waziri B; Raji YE; Ekrikpo UE; Naicker S
J Nephrol; 2023 May; 36(4):1119-1134. PubMed ID: 36510118
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
[TBL] [Abstract][Full Text] [Related]
6. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
[TBL] [Abstract][Full Text] [Related]
7. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
Freedman BI; Limou S; Ma L; Kopp JB
Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
[TBL] [Abstract][Full Text] [Related]
8. A focus on the association of Apol1 with kidney disease in children.
Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
[TBL] [Abstract][Full Text] [Related]
9. APOL1 risk variants and the development of HIV-associated nephropathy.
Goyal R; Singhal PC
FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
[TBL] [Abstract][Full Text] [Related]
10. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Injury in APOL1-associated Kidney Disease.
Ma L; Divers J; Freedman BI
Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
[TBL] [Abstract][Full Text] [Related]
12. APOL1 Genetic Variants Are Associated with Serum-Oxidized Low-Density Lipoprotein Levels and Subclinical Atherosclerosis in South African CKD Patients.
Hassan MO; Duarte R; Dickens C; Dix-Peek T; Naidoo S; Vachiat A; Grinter S; Manga P; Naicker S
Nephron; 2020; 144(7):331-340. PubMed ID: 32526749
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
Elliott MD; Marasa M; Cocchi E; Vena N; Zhang JY; Khan A; Krishna Murthy S; Bheda S; Milo Rasouly H; Povysil G; Kiryluk K; Gharavi AG
J Am Soc Nephrol; 2023 May; 34(5):909-919. PubMed ID: 36758113
[TBL] [Abstract][Full Text] [Related]
14. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
15. APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story.
Kruzel-Davila E; Wasser WG; Skorecki K
Semin Nephrol; 2017 Nov; 37(6):490-507. PubMed ID: 29110756
[TBL] [Abstract][Full Text] [Related]
16. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants of
Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA;
Kidney Int Rep; 2022 Apr; 7(4):786-796. PubMed ID: 35497797
[TBL] [Abstract][Full Text] [Related]
18. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
[TBL] [Abstract][Full Text] [Related]
19.
Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
[TBL] [Abstract][Full Text] [Related]
20. An African perspective on the genetic risk of chronic kidney disease: a systematic review.
George C; Yako YY; Okpechi IG; Matsha TE; Kaze Folefack FJ; Kengne AP
BMC Med Genet; 2018 Oct; 19(1):187. PubMed ID: 30340464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
